HHS FDA Updates Draft Guidance on Manufacturer Communications With Health Care Payors
June 04, 2026
June 04, 2026
WASHINGTON, June 4 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration has released a revised draft guidance outlining how drug and medical device manufacturers may communicate health care economic information to payors, formulary committees and similar organizations involved in coverage and reimbursement decisions. The guidance, titled "Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities--Questions and Ans . . .